Sodium 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate, 72.0%, 100g

Dimethylphenylvinylsilane>98.0%(GC)5g

3-Oxo-N-(p-tolyl)butanamide, 98.0%, 25g

2-(4-Fluoro-phenoxy)-ethylamine, 95.0%, 5g

2-Amino-6-fluoropyridine, 98.0%, 50g

alpha-Cyclohexylphenylacetic Acid>95.0%(GC)(T)1g

tert-Butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 97%, 100mg

4-CHLORO-6-CYCLOPROPYLPYRIMIDIN-2-AMINE, 95%, 250mg

1-Bromo-2,3-bis(bromomethyl)benzene, 95.0%, 5g

Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, 95.0%, 100mg

(S)-2-(2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)acetic acid, 95.0%, 1g

6-Chloro-3-iodo-4-methyl-1-trityl-1H-pyrrolo[3,2-c]pyridine, 95%, 100mg

Warning symbol according to ISO 7010 Individual label, Radioactive substances or ionizing radiation, Side length 100 mm, 1 piece